Tierney Camlin, Lathey Janet L, Christopherson Cindy, Bettendorf Daniel M, D'Aquila Richard T, Hammer Scott M, Katzenstein David A
Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts 02115, USA.
J Infect Dis. 2003 Jan 1;187(1):144-8. doi: 10.1086/345870. Epub 2002 Dec 13.
Human immunodeficiency virus (HIV) type 1 DNA assay data were obtained at baseline from 111 HIV-1-positive subjects who were treated with nucleosides. Higher baseline DNA level, HIV-1 RNA level, and infectious titer were comparably associated with an increased hazard of disease progression (each P<.03). Only DNA level was significantly associated with survival (adjusted hazard ratio for 1 log(10) higher level, 3.99; 95% confidence interval, 1.44-11.09; P=.008).